We examined whether various clinical parameters of prostate cancer, i.e. clinical T stage, PSA recurrence, lymph node metastasis and prostatic capsule invasion, were associated with changes in BIRC6 protein expression. This evidence concerns the gene BIRC6 and Familial prostate cancer.